SJ-106C, a SIRT inhibitor, exhibits IC50 values of 0.59, 0.12, and 0.49 µM against SIRT1/2/3, respectively. This compound specifically targets mitochondria and inhibits the growth of DLBCL tumors.
Target:
Mitochondrial Metabolism|||Sirtuin
* VAT and and shipping costs not included. Errors and price changes excepted
